Federal contract award

FA238423FB001

BIOTECHNOLOGY FOR HUMAN HEALTH AND PERFORMANCE

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeFA2384 USAF AFMC AFRL PZL AFRL RAKH
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAC12 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
Parent award / vehicleFA865019D6109
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$15.0M
Current contract value$15.0M
Potential contract value / ceiling$15.0M
Start dateSep 20, 2023
Current end dateAug 26, 2027
Potential end dateAug 26, 2027
Latest award activityJun 5, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 19 of 19 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 5, 2026P00018$0BIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE.
Feb 12, 2026P00017$0SEE SECTION J ATTACHMENT 1 SOW ENTITLED, BIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE.
Jan 26, 2026P00016$664.7KMOLECULAR ASSESSMENT SENSING TECHNOLOGIES
Dec 3, 2025P00015$0SEE SECTION J ATTACHMENT 1 SOW ENTITLED, BIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE.
Sep 10, 2025P00014$72.6KSEE SECTION J ATTACHMENT 1 SOW ENTITLED, BIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE.
Jul 21, 2025P00013$50.0KSEE SECTION J ATTACHMENT 1 SOW ENTITLED, BIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE.
May 20, 2025P00012$3.2KSEE SECTION J ATTACHMENT 1 SOW ENTITLED, BIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE.
Dec 19, 2024P00011$150.0KBIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE.
Nov 8, 2024P00010$95.7KSEE SECTION J ATTACHMENT 1 SOW ENTITLED, BIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE.
Sep 26, 2024P00009$43.3KBIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE
Sep 24, 2024P00008$4.1KBIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE
Sep 10, 2024P00007$566.0KBIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE
Aug 5, 2024P00006$1.4MSEE SECTION J ATTACHMENT 1 SOW ENTITLED, BIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE.
Jun 4, 2024P00005$525.2KSEE SECTION J ATTACHMENT 1 SOW ENTITLED, BIOTECHNOLOGY FOR HEALTH AND HUMAN PERFORMANCE.
Mar 21, 2024P00004$526.0KBIOTECHNOLOGY FOR HUMAN HEALTH AND PERFORMANCE - INCREMENTAL FUNDING
Jan 30, 2024P00003$214.8KBIOTECHNOLOGY FOR HUMAN HEALTH AND PERFORMANCE - INCREMENTAL FUNDING
Nov 16, 2023P00002$1.3MBIOTECHNOLOGY FOR HUMAN HEALTH AND PERFORMANCE - INCREMENTAL FUNDING
Sep 26, 2023P00001$102.9KBIOTECHNOLOGY FOR HUMAN HEALTH AND PERFORMANCE - INCREMENTAL FUNDING
Sep 18, 20230$9.2MBIOTECHNOLOGY FOR HUMAN HEALTH AND PERFORMANCE

Estimated positioning window

Oct 25, 2026 – Feb 26, 2027

Recompete signal:
75/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 75/100. Available recorded signals: 70 points.

Contract end 2027-08-26 (305 days from calculation)
+35 points
47 historical awards in this buyer and category group
+15 points
19 recorded award transactions
+10 points
Latest award action: 2026-06-05
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+0 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.